Abstract Introduction: Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus (DM). In general, DKA characterized by blood sugar over 250 mg/dL, anion-gap metabolic acidosis, and increased plasma or urine ketones. Approximately 2–3% patients can present with normal glucose levels (less than mg/dl) which called euglycemic DKA. Some the etiologies include recent use i...

BACKGROUND Sodium glucose co-transporter 2 (SGLT2) inhibitors are a new class of pharmacologic agents developed for the treatment of type 2 diabetes mellitus (T2DM). Their unique mechanism of action is independent of pancreatic beta-cell function or the degree of insulin resistance, giving these agents the potential for use in combination with any of the existing classes of glucose-lowering age...

The pathogenesis of post-gastrectomy reactive hyperinsulinaemic hypoglycaemia is not yet fully clarified. Recent studies suggest an up-regulation the intestinal glucose transporter SGLT-1 aimed to prevent carbohydrate malabsorption. overexpression could therefore represents one mechanisms underlying wide glycemic excursions found in patients after gastrectomy, but investigating use SGLT-1/SGLT-...